Filing Details

Accession Number:
0001209191-19-023564
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-03 21:03:28
Reporting Period:
2019-04-01
Accepted Time:
2019-04-03 21:03:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1731348 Tilray Inc. TLRY Medicinal Chemicals & Botanical Products (2833) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746057 Jr Wood Edward Pastorius 1100 Maughan Road
Nanaimo A1 V9X IJ2
Chief Revenue Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class 2 Common Stock Acquisiton 2019-04-01 43,750 $7.76 58,455 No 4 M Direct
Class 2 Common Stock Disposition 2019-04-01 34,088 $63.08 24,367 No 4 S Direct
Class 2 Common Stock Disposition 2019-04-01 6,600 $64.14 17,767 No 4 S Direct
Class 2 Common Stock Disposition 2019-04-01 3,062 $64.80 14,705 No 4 S Direct
Class 2 Common Stock Acquisiton 2019-04-01 6,250 $0.00 20,955 No 4 M Direct
Class 2 Common Stock Disposition 2019-04-02 2,807 $63.78 18,148 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class 2 Common Stock Stock Option (Right to Buy) Disposition 2019-04-01 43,750 $0.00 43,750 $7.76
Class 2 Common Stock Restricted Stock Units Disposition 2019-04-01 6,250 $0.00 6,250 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
306,250 2028-05-20 No 4 M Direct
43,750 2019-04-01 No 4 M Direct
Footnotes
  1. The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.80 to $63.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote 3 to this Form 4.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.80 to $64.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote 4 to this Form 4.
  5. Each restricted stock unit converted into one share of Class 2 Common Stock.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.50 to $64.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote 6 to this Form 4.
  7. The shares shall vest at the rate of 25% of the shares on the twelve (12) month anniversary of April 1, 2018 (the "Vesting Commencement Date"), and the remaining option shares will vest quarterly thereafter at the rate of 6.25% of the total number of shares on each quarterly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person remains in Continuous Service (as defined in the Company's 2018 Equity Incentive Plan), such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
  8. The remaining RSUs will vest quarterly at a rate of 6.25% of the total number of RSUs on each quarterly anniversary of January 1, 2017 (the "Vesting Commencement Date") for so long as the Reporting Person remains in Continuous Service (as defined in the Company's 2018 Equity Incentive Plan), such that the total number of RSUs shall be fully vested on the four-year anniversary of the Vesting Commencement Date.